Today, CellaVision announced that the company's Annual Report for 2010 is
available as PDF atwww.cellavision.com, and can be read via the link below.
To request a printed version, please visit CellaVision's website.
For more information, please contact:
Yvonne MÃ¥rtensson, CEO. Phone: +46 708 33 77 82, e-
mail:yvonne.martensson@cellavision.com
Johan Wennerholm, CFO. Phone: +46 708 33 81 68, e-
mail:johan.wennerholm@cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The analyses often constitute important
reference data for fast and correct diagnosis of illnesses, for example of
infections and serious cancers. CellaVision's products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge expertise
in image analysis, artificial intelligence and automated microscopy. In 2010
sales were SEK 132 million and sales continue to increase, with a growth target
of at least 15 % per year over an economic cycle. CellaVision's registered
office is in Lund and the company has subsidiaries in the USA, Canada and Japan.
The share is listed on the Nasdaq, OMX Stockholm, Small Cap list. Read more
atwww.cellavision.com.
CellaVision Annual Report 2010:
http://hugin.info/132164/R/1503160/438154.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1503160]